Schedule of Share-based compensation expense (Details) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]
Selling, general and administrative expenses	$ 2,728,852	$ 875,509
Research and development expenses	805,217	220,723
Cost of revenues	9,032	18,535
Total	$ 3,543,101	$ 1,114,767